Hospital Adaptions to Mitigate the COVID-19 Pandemic Effects on MARQUIS Toolkit Implementation and Sustainability

Abstract

ABSTRACT Objective: To explore the perceived effects of COVID-19 on MARQUIS toolkit implementation and sustainability, challenges faced by hospitals in sustaining medication reconciliation efforts, and the strategies used to mitigate the negative effects of the pandemic. Data Sources and Study Settings: Primary qualitative data were extracted from a Web-based survey. Data were collected from hospitals that participated in MARQUIS2 (n = 18) and the MARQUIS Collaborative (n = 5). Study Design: A qualitative, cross-sectional study was conducted. Data Collection/Data Extraction: Qualitative data were extracted from a Research Electronic Data Capture survey databased and uploaded into an Excel data analysis template. Two coders independently coded the data with a third coder resolving discrepancies. Principal Findings: Thirty-one team members participated, including pharmacists (n = 20; 65%), physicians (n = 9; 29%), or quality-improvement (QI) specialists (n = 2; 6%) with expertise in medication reconciliation (MedRec) (14; 45%) or QI (10; 32%). Organizational resources were limited, including funding, staffing, and access to pharmacy students. To support program continuation, hospitals reallocated staff and used new MedRec order sets. Telemedicine, workflow adaptations, leadership support, QI team involvement, and ongoing audits and feedback promoted toolkit sustainability. Conclusions: COVID-19 affected the capacity of hospitals to sustain the MARQUIS toolkit. However, hospitals adapted various strategies to sustain the toolkit.